Enfusion To Present at Upcoming Investor Events
Enfusion (NYSE: ENFN), a top SaaS provider for investment managers, announced participation in two investor events. CEO Oleg Movchan, CFO Brad Herring, and COO Neal Pawar will present at William Blair’s 44th Annual Growth Stock Conference on June 5, 2024, and Morgan Stanley US Financials, Payments & CRE Conference on June 12, 2024. Live audio webcasts and replays will be accessible on Enfusion's Investor Relations website.
- Participation in high-profile investor conferences, enhancing visibility.
- Opportunity to attract potential investors and stakeholders.
- Showcase leadership team's insights and company's strategic direction.
- No direct financial improvements or business milestones announced.
- Potential investor fatigue from repeated presentations if not managed well.
- Implicit cost associated with participation not disclosed.
- William Blair’s 44th Annual Growth Stock Conference on Wednesday, June 5, 2024
- Morgan Stanley US Financials, Payments & CRE Conference on Wednesday, June 12, 2024
Live audio webcasts and archived replays of the events will be available in the Events & Presentations section of the Enfusion Investor Relations website at http://ir.enfusion.com.
About Enfusion
Enfusion's investment management software-as-a-service platform removes traditional information boundaries, uniting front-, middle- and back-office teams on one system. Through its software, analytics, and middle/back-office managed services, Enfusion creates enterprise-wide cultures of real-time, data-driven intelligence and collaboration boosting agility and powering growth. Enfusion partners with over 850 investment managers from 9 global offices spanning four continents.
Source: Enfusion, Inc.
Source Code: ENFN-IR
View source version on businesswire.com: https://www.businesswire.com/news/home/20240529848501/en/
Investors
Bill Wright
investors@enfusion.com
Media
media@enfusion.com
Source: Enfusion, Inc.
FAQ
What investor events is Enfusion (ENFN) attending in June 2024?
Who will represent Enfusion (ENFN) at the upcoming investor events?